Fresh Tracks Therapeutics Inc
FRTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.59M
Close$
Share Statistics
| Market cap | $5.59 Million |
|---|---|
| Enterprise Value | $-5,282,955.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.96 |
| Beta | 1.17 |
| Outstanding Shares | 5,912,786 |
Return
| Return on Equity | -56.72% |
|---|---|
| Return on Assets | -48.61% |
| Return on Invested Capital | -59.16% |
Valuation & Multiples
| P/E Ratio | -0.97 |
|---|---|
| PEG | 1.34 |
| Price to Sales | 0.94 |
| Price to Book Ratio | 0.94 |
| Enterprise Value to Revenue | -0.66 |
| Enterprise Value to EBIT | 0.9 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fresh Tracks Therapeutics Inc
13 employees
CEO: Robert Brown Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for...